<DOC>
	<DOCNO>NCT02591537</DOCNO>
	<brief_summary>Twelve acute wound ( 6 either side umbilicus ) surgically create low abdominal area . One side umbilicus randomize Oxygenesys treatment arm side receive standard Tegaderm treatment arm . Time wound heal observe 14 day .</brief_summary>
	<brief_title>OxyGenesys Dissolved Oxygen Dressing ; Abdominoplasty Northwestern University</brief_title>
	<detailed_description>At least 12 study visit occur 3 month timeframe . Twelve acute wound ( 6 either side umbilicus ) surgically create low abdominal area . One side umbilicus randomize Oxygenesys treatment arm side receive standard Tegaderm treatment arm . Time wound heal observe 14 day ( follow assessment include wound photography , pain score , wound biopsy , exudate collection , gene expression proteomic analysis , scar assessment adverse event collection . Study visit occur : Prescreening Visit ; Day wound ; Day 2 ; Day 7 ; Day 8-14 ( wound heal ) ; Day 28 ; Day 42 ; Day 90 ; Abdominoplasty Surgery . An abdominoplasty occur day 90 .</detailed_description>
	<criteria>Males nonpregnant female age 2185 year . Female subject child bear potential must use method ( ) contraception acceptable Investigator agree least screening visit one month administration final study dress . Subject willing undergo creation twelve experimental donor sit 1.0 '' x 1.0 '' size depth 0.0012 '' 0.0018 '' take abdomen per modification Northwestern Abdominoplasty Scar Model Subjects medically acceptable candidate abdominoplasty ( BMI approximately 2535 kg/m2 ) determine perstudy laboratory assessment clinical evaluation . Willingness provide informed consent comply requirement protocol full duration study . Subjects receive treatment systemic steroid 30 day prior study enrollment . Subjects receive immunosuppressive drug , radiation chemotherapy three month prior study enrollment . Subjects history malignancy previous three year . Subjects uncontrolled diabetes ( A1C &gt; 8 % ) . Subjects current smoker significant packyear history smoking ( &gt; 1 packyear ) . Subjects diseases condition could , opinion Investigator , interfere assessment safety , tolerability efficacy . Subjects previously skin graft harvest area study . Subjects skin disorder ( chronic venous ulcer ) chronic currently active Investigator considers adversely affect heal acute wound involve area examine trial . Subjects extensive severe stria would make difficult perform skin graft abdomen and/or evaluate final scar appearance . Subjects history clinical significant hypersensitivity surgical dressing use trial . Subjects take , take Investigational drug within 3 month prior screen visit . Subjects participate research Investigations . Subjects require treatment medication ( ) know interfere wound healing . Subjects become pregnant include Day 0 lactating . Subjects , opinion Investigator , likely complete trial whatever reason , include significant comorbidities may adversely affect survival ability attend follow visit .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>